Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
We think thats a signal worth investigating. Ungar has studied online health discussions for years, including early efforts in 2011 to extract information about drug side effects from user-generated content
Lown M, Fuller R, Lightowler H, Fraser A, Gallagher A
This question has gained attention as GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) become increasingly prescribed for type 2 diabetes and weight management
A recent review involving nearly 10,000 people found no clear increase in pancreatitis risk the results suggested a possible higher risk, but they were too uncertain to say for sure
Although theyre not new, GLP-1 medications have exploded in the field of weight management recently
Food stays in your stomach longer, making you feel fuller during and after meals
